AIM-listed biotech firms face crunch votes on London Stock Exchange exits April 14, 2024 Redx Pharma and C4X Discovery have scheduled general meetings this week to vote on proposals for delisting from the London Stock Exchange.
City chiefs lament London Stock Exchange ‘doom loop’ after bruising exits April 13, 2024 Two top City figures have taken aim at the “doom loop” and negative media narrative gripping the London Stock Exchange after a bruising week of headlines for the beleaguered bourse.
‘Lack of appetite’ in London drives another high-tech firm to Nasdaq April 10, 2024 In a statement to markets this morning, London-HQd e-therapeutics said it has "an intention to cancel its admission to AIM and subsequently explore the option of listing on NASDAQ in due course."
‘Incredible spin’: Sadiq Khan slated for linking rising crime to cost of living crisis March 15, 2024 Sadiq Khan has been blasted for “incredible spin” over his linking the cost of living crisis to increasing crime in London.
How to cure the City’s depression? Some retail investor therapy February 16, 2024 The London Stock Exchange needs wide reform, but recentering the role of retail investors could be a shot in the arm, writes Fraser Thorne.
Air Astana set for £671m valuation ahead of milestone London IPO February 9, 2024 Air Astana has bagged an $847m valuation from investors as it gears up for a Valentines Day IPO that will be seen as a test of the health of London’s beleaguered listings market.
Only fast fixes can save the London Stock Exchange from a 2024 exodus February 9, 2024 The London Stock Exchange has been bruised and battered over the past two years. James Ashton, CEO of the Quoted Companies Alliance, warns the Chancellor the time is now for action
Neighbourhood watch: Keeping a close eye on the London Stock Exchange February 6, 2024 In the last couple of years, London's exchanges - particularly the flagship bourse, the London Stock Exchange - have been under scrutiny like never before.
Reneuron issues administration warning as biotech firm puts jobs at risk February 5, 2024 Biotech business ReNeuron Group has warned it could enter administration and is preparing to make redundancies as its shares were suspended from trading.
The surprise fall that shows just how much trouble the London Stock Exchange is in January 29, 2024 The value of listed firms on the London Stock Exchange is now ony four-fifths of what it was a decade ago: Read more